[et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.16″ background_image=”https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/03\/investor-banner.jpg” parallax=”on” da_disable_devices=”off|off|off” saved_tabs=”all” collapsed=”off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_fullwidth_header title=”Investor Information” header_fullscreen=”on” button_one_url=”#visionvalues” button_two_url=”#codeofconduct” _builder_version=”4.16″ title_font=”|700|||||||” title_text_color=”#f7941e” title_font_size=”40px” title_line_height=”1.2em” content_font=”||||||||” content_text_color=”#000000″ content_line_height=”1.8em” subhead_font=”||||||||” subhead_text_color=”rgba(0,0,0,0.6)” subhead_font_size=”22px” subhead_line_height=”1.4em” background_color=”rgba(255,255,255,0.7)” custom_button_one=”on” button_one_text_size=”20px” button_one_text_color=”#ffffff” button_one_bg_color=”#f7941e” button_one_border_width=”0px” button_one_font=”|||on|||||” button_one_use_icon=”off” custom_button_two=”on” button_two_text_size=”20px” button_two_text_color=”rgba(0,0,0,0.7)” button_two_bg_color=”#ffffff” button_two_border_width=”0px” button_two_font=”|||on|||||” button_two_use_icon=”off” button_two_custom_margin=”||||false|false” button_two_custom_margin_tablet=”” button_two_custom_margin_phone=”|||1px|false|false” button_two_custom_margin_last_edited=”on|desktop” button_two_custom_padding=”||||false|false” background_layout=”light” width=”50%” width_tablet=”” width_phone=”100%” width_last_edited=”on|phone” animation_style=”fade” animation_duration=”500ms” animation_delay=”300ms” title_font_tablet=”” title_font_phone=”” title_font_last_edited=”on|phone” content_font_tablet=”” content_font_phone=”” content_font_last_edited=”on|phone” global_colors_info=”{}”]At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.[\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ background_color=”rgba(0,0,0,0)” da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_row _builder_version=”4.27.4″ width=”90%” max_width=”2560px” custom_padding=”0px||0px||true|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
[\/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_line_height=”1.8em” header_font=”|700|||||||” header_text_color=”#000000″ header_font_size=”25px” header_line_height=”1.2em” header_2_font=”|700|||||||” header_2_text_color=”#000000″ header_2_font_size=”25px” header_2_line_height=”1.2em” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]Details of Independent Directors\u2019 Familiarization Program for 2025-26<\/a><\/p>\n Supplier & Third-Party Code of Conduct<\/a><\/p>\n Policy for Determining Material Subsidiary<\/a><\/p>\n Policy for Preservation of documents and Archival<\/a><\/p>\n Details of Independent Directors\u2019 Familiarization Program for 2024-25<\/a><\/p>\n Global Code of Conduct<\/a><\/p>\n Policy on Materiality of and Dealing with Related Party Transactions<\/a><\/p>\n Code of Conduct for Prohibition of Insider Trading<\/span><\/a><\/p>\n ODR Disclosure Policy<\/span><\/a><\/p>\n Details of Independent Directors\u2019 Familiarization Program for 2023-24<\/span><\/a><\/p>\n Biodiversity Policy<\/span><\/a><\/p>\n Policy for determining Materiality of Events or Information<\/span><\/a><\/p>\n Details of Independent Directors\u2019 Familiarization Program for 2022-23<\/span><\/a><\/p>\n Business Responsibility and Sustainability Policy<\/a><\/p>\n Human Rights Policy<\/a><\/p>\n Role and Responsibilities of Lead Independent Director<\/a><\/p>\n Synopsis of Risk Management Policy<\/a><\/p>\n Board Diversity Policy<\/a><\/p>\n Tax Policy<\/a><\/p>\n Details of Independent Directors\u2019 Familiarization Program for 2021-22<\/a><\/p>\n Corporate Social Responsibility Policy<\/a><\/p>\n Details of Independent Directors\u2019 Familiarization Program for 2020-21<\/a><\/p>\n Details of Independent Directors\u2019 Familiarization Program for 2019-20<\/a><\/p>\n Remuneration Policy<\/a><\/p>\n Details of Independent Directors Familiarization Programme 2018-19<\/a><\/p>\n Whistle Blower Policy for Sun Pharmaceutical Industries Limited & its Subsidiaries<\/a><\/p>\n Details of Independent Directors Familiarization Programme 2017-2018<\/a><\/p>\n SPIL Compliance Policy Effective 11-08-2017<\/a><\/p>\n Details of Independent Directors Familiarization Programme 2016-2017<\/a><\/p>\n Dividend Distribution Policy<\/a><\/p>\n Details of Independent Directors\u2019 Familiarization Program for FY 2015-2016<\/a><\/p>\n Archival Policy<\/a><\/p>\n Code of Fair Disclosure<\/a><\/p>\n Details of Independent Directors Familiarisation Programme<\/a><\/p>\n